Evidence map›Paper›PMID 42196736›Full record

ArticleInternational journal of environmental research and public health2026

Leveraging Machine Learning to Assess Post-COVID-19 Glycemic Control in Diabetic Patients.

Marie Lluberes-Contreras, Eduardo Figueroa-Santiago, Hamid-Reza Kohan-Ghadr, Angel Ortiz-Ortega, Abiel Roche-Lima, N3C Consortium

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marie Lluberes-ContrerasBioinformatics and Data Science Laboratory, Department of Computer Science, University of Puerto Rico, San Juan, PR 00925, USA.ORCID 0000-0002-4466-0786
Eduardo Figueroa-SantiagoDepartment of Computer Science, University of Puerto Rico, San Juan, PR 00925, USA.ORCID 0009-0003-7011-0918
Hamid-Reza Kohan-GhadrSysBioSolutions LLC, Portage, MI 49024, USA.
Angel Ortiz-OrtegaMedresearch LLC, Caguas, PR 00725, USA.
Abiel Roche-LimaCenter for Collaborative Research in Health Disparities, Medical Sciences Campus, University of Puerto Rico, San Juan, PR 00936, USA.ORCID 0000-0003-2246-6744
N3C Consortium

Funding

NIH HHS U54-MD007600 1OT2OD032581-01
6 · The paper itself

Abstract

Hemoglobin A1c is a central biomarker for long-term glycemic control and a key predictor of diabetes-related complications. The COVID-19 pandemic disrupted routine healthcare delivery and introduced potential metabolic effects of SARS-CoV-2 infection, yet the long-term impact of COVID-19 on glycemic trajectories in individuals with diabetes remains unclear. In this retrospective study, we leveraged harmonized electronic health record data from the National Clinical Cohort Collaborative to evaluate changes in HbA1c before and after documented SARS-CoV-2 infection in adults with diabetes (

Indexed as

COVID-19Diabetes MellitusGlycated HemoglobinGlycemic ControlMachine LearningAgedBlood GlucoseElectronic Health RecordsFemaleHumansHypoglycemic AgentsMaleMiddle AgedPredictive Learning ModelsRetrospective StudiesSARS-CoV-2Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsCOVID-19diabetesdisease diagnosiselectronic health recordsepidemic predictionHbA1cmachine learning

Identifiers

PMID42196736
PMCPMC13206707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.